
Pennywise is an indica-dominant, high-CBD hybrid created by crossing Harlequin with AC/DC. This strain was specifically bred for therapeutic users seeking the medical benefits of cannabis with a balanced CBD:THC ratio that minimizes psychoactive intensity while maximizing therapeutic relief. The Harlequin parent contributes its well-documented high-CBD genetics and clear-headed character, while the AC/DC parent brings exceptional CBD potency (AC/DC is one of the highest-CBD strains available, often testing at CBD:THC ratios of 20:1 or higher). The result is a cultivar that delivers meaningful therapeutic relief with a moderated psychoactive experience, making it suitable for patients who need daytime functionality. Its earthy-peppery-sweet aroma is pleasant and approachable, and its indica-dominant structure provides gentle body relaxation that complements the CBD-driven therapeutic effects.
| Attribute | Value |
|---|---|
| Type | Indica-Dominant Hybrid (High-CBD) |
| THC % | 3-8% |
| CBD % | 8-15% |
| Dominant Terpenes | Caryophyllene, Humulene, Myrcene |
| Flowering Time | 55-65 days |
| Yield | Moderate (300-400 g/m² indoor) |
| Growing Difficulty | Moderate |
Pennywise is a two-way cross of high-CBD genetics:
Parent lineage: Harlequin x AC/DC
Pennywise was bred to combine the best of two high-CBD lineages. The Harlequin genetics contribute the well-documented therapeutic profile and clear-headed character, while the AC/DC parent pushes the CBD ratio even higher. The result is a strain that delivers meaningful CBD-driven therapeutic relief with enough THC to provide the entourage effect (the synergistic interaction between cannabinoids and terpenes) without overwhelming psychoactive effects. This balanced CBD:THC ratio is considered ideal for many medical applications, as research suggests that the combination of CBD and THC together can be more effective than either cannabinoid alone for certain conditions.
| Cannabinoid | Typical Range |
|---|---|
| THC (Total) | 3-8% |
| CBD | 8-15% |
| CBG | 0.5-1.5% |
| CBN | <0.5% (increases with age) |
The low THC and high CBD range is the defining feature of Pennywise. The CBD:THC ratio typically falls between 2:1 and 5:1, which is considered optimal for many therapeutic applications. The moderated THC provides enough psychoactive character to enhance the entourage effect while the high CBD delivers the primary therapeutic relief.
| Terpene | Approximate Share | Notes |
|---|---|---|
| Caryophyllene | 25-40% | Primary terpene; spicy, peppery with anti-inflammatory properties |
| Humulene | 15-25% | Significant presence; earthy, woody with reported anti-inflammatory effects |
| Myrcene | 10-20% | Earthy, herbal base contributing to body relaxation |
| Pinene | 3-8% | Subtle pine freshness |
| Linalool | 2-5% | Floral sweetness with calming associations |
The caryophyllene-humulene-myrcene combination produces Pennywise's distinctive earthy-peppery-sweet aroma. Caryophyllene is notable as the only terpene known to directly interact with the body's endocannabinoid system (CB2 receptors), which may enhance the strain's therapeutic profile when combined with high CBD content.
Pennywise is widely reported to produce:
Onset: Effects begin within minutes when smoked or vaporized; 30-90 minutes when consumed orally.
Duration: 2-3 hours for inhaled consumption; 4-6 hours for oral consumption.
Intensity: Mild. The high CBD and low THC produce a gentle experience focused on therapeutic relief rather than intoxication.
⚠️ Effects are self-reported and vary by individual, dose, tolerance, and consumption method. Not a prediction of any individual's experience. Pennywise is bred for therapeutic use and is generally well-tolerated, but individual responses to CBD:THC ratios vary.
Not Medical Advice -- The following lists commonly reported therapeutic applications. This does not constitute medical advice. Consult a healthcare professional before using cannabis therapeutically.
Commonly reported uses include:
Commonly reported adverse effects:
| Attribute | Details |
|---|---|
| Difficulty | Moderate -- high-CBD genetics require attention to cannabinoid expression and environmental stability |
| Flowering Time | 55-65 days (indoor) |
| Yield | 300-400 g/m² indoor; 350-450 g/plant outdoor |
| Plant Height | Short to medium -- indica-dominant compact structure |
| Preferred Environment | Indoor or outdoor; prefers stable, controlled conditions for optimal CBD expression. |
| Resistance | Moderate resistance to mold and pests. The high-CBD genetics may contribute some natural pest resistance. Responds well to topping, LST, and SCROG. The compact structure is manageable indoors. Outdoor harvest in the Northern Hemisphere typically falls in early to mid-October. |
Pennywise is a moderately manageable strain to grow. High-CBD genetics benefit from stable, controlled environments to ensure optimal cannabinoid expression. The indica-dominant compact structure is an advantage for indoor cultivation. The moderate yields are consistent with therapeutic-focused genetics, where quality and cannabinoid profile are prioritized over volume.
Back to Strain Database | Hybrid Strains | Strain Template Guide